ISSN: 1473-7140

Journal Home

Journal Guideline

Expert Review of Anticancer Therapy Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Review of Anticancer Therapy is a journal indexed in SJR in Oncology and Pharmacology (medical) with an H index of 88. It has a price of 4000 €. It has an SJR impact factor of 0,926 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,926.

Expert Review of Anticancer Therapy focuses its scope in these topics and keywords: cancer, breast, metastatic, therapy, colorectal, advanced, chemotherapy, lung, livertreatment, lymphoma, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Oncology (Q2) Pharmacology (medical) (Q2)

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,926

SJR Impact factor

88

H Index

121

Total Docs (Last Year)

371

Total Docs (3 years)

8182

Total Refs

1041

Total Cites (3 years)

345

Citable Docs (3 years)

2.58

Cites/Doc (2 years)

67.62

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

International Journal of Oncology Q2
Cancer Cytopathology Q2
Cancer Causes & Control Q2
BMC Cancer Q2
Current Opinion in Oncology Q2

Compare this journals